Search research articles
Contact Us
Filters
Showing results (131-140 of 247) with videos related to
Page
of 25
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
April 17, 2007
Dipyrone elicits substantial inhibition of peripheral cyclooxygenases in humans: new insights into the pharmacology of an old analgesic
Burkhard Hinz, Olga Cheremina, Jouri Bachmakov, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
December 6, 2025
A quantitative, broad-panel LC-MS/MS method for the analysis of intact steroid conjugates: A novel approach to steroid profiling for biomarker research in corticoid-dependent diseases
Eleanor North, Arne Gessner, Max Kurlbaum, et al.
Frontiers in Pharmacology
|
March 24, 2025
Clinical-pharmaceutical assessment of medication CDSS alerts: content appropriateness and patient relevance in clinical practice
Jacqueline Bauer, Marika Busse, Sonja Koch, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen
|
March 7, 2022
[Economic aspects in the care of patients with new oral anticancer drugs: findings from the AMBORA trial]
Pauline Dürr, Katja Schlichtig, Sabine Krebs, et al.
Deutsches Arzteblatt International
|
January 3, 2023
The Psychopharmacological Treatment of People With Severe Dementia-Findings of a Cross-Sectional Study
Kristina Diehl, André Kratzer, Carolin Donath, et al.
Journal of Molecular and Cellular Cardiology
|
June 19, 2012
Interaction of the cardiovascular risk marker asymmetric dimethylarginine (ADMA) with the human cationic amino acid transporter 1 (CAT1)
Joachim Strobel, Maren Mieth, Beate Endress, et al.
Circulation
|
February 2, 1999
Inhibition of P-glycoprotein-mediated drug transport: A unifying mechanism to explain the interaction between digoxin and quinidine [seecomments]
M F Fromm, R B Kim, C M Stein, et al.
Clinical Pharmacology and Therapeutics
|
December 6, 2022
Development in Prescriptions of Contraindicated and Potentially Harmful QT Interval-Prolonging Drugs in a Large Geriatric Inpatient Cohort From 2011 to 2021
Melanie I Then, Thomas Tümena, Anna Sledziewska, et al.
Pain
|
August 1, 1997
Loss of analgesic effect of morphine due to coadministration of rifampin
M F Fromm, K Eckhardt, S Li, et al.
Journal of Clinical Medicine
|
November 11, 2022
Characteristics and Cost of Unscheduled Hospitalizations in Patients Treated with New Oral Anticancer Drugs in Germany: Evidence from the Randomized AMBORA Trial
Pauline Dürr, Florian Meier, Katja Schlichtig, et al.
Page
of 25
Search research articles
Search
Showing results (131-140 of 247) with videos related to
Sort By:
Page
of 25
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
April 17, 2007
Dipyrone elicits substantial inhibition of peripheral cyclooxygenases in humans: new insights into the pharmacology of an old analgesic
Burkhard Hinz, Olga Cheremina, Jouri Bachmakov, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
December 6, 2025
A quantitative, broad-panel LC-MS/MS method for the analysis of intact steroid conjugates: A novel approach to steroid profiling for biomarker research in corticoid-dependent diseases
Eleanor North, Arne Gessner, Max Kurlbaum, et al.
Frontiers in Pharmacology
|
March 24, 2025
Clinical-pharmaceutical assessment of medication CDSS alerts: content appropriateness and patient relevance in clinical practice
Jacqueline Bauer, Marika Busse, Sonja Koch, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen
|
March 7, 2022
[Economic aspects in the care of patients with new oral anticancer drugs: findings from the AMBORA trial]
Pauline Dürr, Katja Schlichtig, Sabine Krebs, et al.
Deutsches Arzteblatt International
|
January 3, 2023
The Psychopharmacological Treatment of People With Severe Dementia-Findings of a Cross-Sectional Study
Kristina Diehl, André Kratzer, Carolin Donath, et al.
Journal of Molecular and Cellular Cardiology
|
June 19, 2012
Interaction of the cardiovascular risk marker asymmetric dimethylarginine (ADMA) with the human cationic amino acid transporter 1 (CAT1)
Joachim Strobel, Maren Mieth, Beate Endress, et al.
Circulation
|
February 2, 1999
Inhibition of P-glycoprotein-mediated drug transport: A unifying mechanism to explain the interaction between digoxin and quinidine [seecomments]
M F Fromm, R B Kim, C M Stein, et al.
Clinical Pharmacology and Therapeutics
|
December 6, 2022
Development in Prescriptions of Contraindicated and Potentially Harmful QT Interval-Prolonging Drugs in a Large Geriatric Inpatient Cohort From 2011 to 2021
Melanie I Then, Thomas Tümena, Anna Sledziewska, et al.
Pain
|
August 1, 1997
Loss of analgesic effect of morphine due to coadministration of rifampin
M F Fromm, K Eckhardt, S Li, et al.
Journal of Clinical Medicine
|
November 11, 2022
Characteristics and Cost of Unscheduled Hospitalizations in Patients Treated with New Oral Anticancer Drugs in Germany: Evidence from the Randomized AMBORA Trial
Pauline Dürr, Florian Meier, Katja Schlichtig, et al.
Page
of 25